Latest Insider Transactions at Akero Therapeutics, Inc. (AKRO)
This section provides a real-time view of insider transactions for Akero Therapeutics, Inc. (AKRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akero Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akero Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 25
2022
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,500
-7.11%
|
$550,000
$44.72 P/Share
|
|
Oct 25
2022
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+6.64%
|
$75,000
$6.36 P/Share
|
|
Oct 25
2022
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,653
-5.16%
|
$479,385
$45.09 P/Share
|
|
Oct 25
2022
|
Timothy Rolph Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.36%
|
$170,000
$17.36 P/Share
|
|
Oct 13
2022
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-81.87%
|
$780,000
$39.82 P/Share
|
|
Oct 13
2022
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+45.02%
|
$140,000
$7.01 P/Share
|
|
Oct 10
2022
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.09%
|
$185,000
$37.99 P/Share
|
|
Oct 06
2022
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
22,500
-10.77%
|
$877,500
$39.29 P/Share
|
|
Oct 06
2022
|
Timothy Rolph Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.57%
|
$210,000
$21.09 P/Share
|
|
Oct 03
2022
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-1.05%
|
$330,000
$33.59 P/Share
|
|
Oct 03
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.03%
|
$0
$0.62 P/Share
|
|
Sep 30
2022
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
45,000
-9.7%
|
$1,440,000
$32.72 P/Share
|
|
Sep 30
2022
|
Timothy Rolph Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.99%
|
$260,000
$13.73 P/Share
|
|
Sep 13
2022
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
22,500
-9.13%
|
$652,500
$29.18 P/Share
|
|
Sep 13
2022
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
32,500
-63.32%
|
$877,500
$27.15 P/Share
|
|
Sep 13
2022
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,500
+46.81%
|
$227,500
$7.01 P/Share
|
|
Sep 13
2022
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
40,000
-17.94%
|
$1,080,000
$27.61 P/Share
|
|
Sep 13
2022
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
60,000
-8.38%
|
$1,620,000
$27.22 P/Share
|
|
Sep 13
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+13.95%
|
$0
$0.62 P/Share
|
|
Jun 30
2022
|
Catriona Yale Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,152
+0.93%
|
$9,216
$8.03 P/Share
|
|
Jun 30
2022
|
William Richard White Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,152
+20.64%
|
$9,216
$8.03 P/Share
|
|
Jun 30
2022
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,152
+0.47%
|
$9,216
$8.03 P/Share
|
|
Jun 30
2022
|
Andrew Cheng President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,152
+0.37%
|
$9,216
$8.03 P/Share
|
|
Mar 01
2022
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.13%
|
$170,000
$17.59 P/Share
|
|
Mar 01
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.04%
|
$0
$0.62 P/Share
|
|
Feb 01
2022
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.13%
|
$170,000
$17.56 P/Share
|
|
Feb 01
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.04%
|
$0
$0.62 P/Share
|
|
Jan 14
2022
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,700
-74.75%
|
$213,400
$22.03 P/Share
|
|
Jan 14
2022
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+42.77%
|
$67,900
$7.01 P/Share
|
|
Jan 10
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.13%
|
$0
$0.62 P/Share
|
|
Jan 07
2022
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,744
+14.53%
|
$0
$0.62 P/Share
|
|
Jan 03
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,000
+14.64%
|
$0
$0.62 P/Share
|
|
Dec 21
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
100
-2.96%
|
$2,200
$22.0 P/Share
|
|
Dec 21
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+2.88%
|
$700
$7.01 P/Share
|
|
Dec 17
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,200
-49.41%
|
$70,400
$22.04 P/Share
|
|
Dec 17
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,200
+33.07%
|
$22,400
$7.01 P/Share
|
|
Dec 02
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-6.4%
|
$350,000
$20.18 P/Share
|
|
Nov 04
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,220
-4.39%
|
$149,280
$24.33 P/Share
|
|
Nov 03
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
18,780
-11.7%
|
$450,720
$24.27 P/Share
|
|
Nov 02
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-6.01%
|
$385,000
$22.57 P/Share
|
|
Nov 01
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-66.48%
|
$143,000
$22.24 P/Share
|
|
Nov 01
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+39.93%
|
$45,500
$7.01 P/Share
|
|
Oct 15
2021
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
12,500
-4.69%
|
$262,500
$21.96 P/Share
|
|
Oct 04
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-5.67%
|
$367,500
$21.54 P/Share
|
|
Oct 01
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-66.48%
|
$143,000
$22.06 P/Share
|
|
Oct 01
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+39.93%
|
$45,500
$7.01 P/Share
|
|
Sep 15
2021
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
12,500
-4.34%
|
$300,000
$24.94 P/Share
|
|
Sep 02
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-5.37%
|
$402,500
$23.89 P/Share
|
|
Sep 01
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,559
-72.31%
|
$205,416
$24.0 P/Share
|
|
Sep 01
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,559
+41.97%
|
$59,913
$7.01 P/Share
|